A study by Judd et al. [94] suggested that ERK1/2 signalling regulates CD44 expression in aggressive oral cancer cell lines and that the blockage of ERK1/2 decreased CD44 expression. This evidence concerns the gene CD44 and lip and oral cavity carcinoma.